Literature DB >> 20005336

Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation.

H Petrowsky1, J C Hong.   

Abstract

Cholangiocarcinoma (CCA) is a rare but devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. Surgical resection is the only chance for cure or long-term survival. The treatment of CCA has remained challenging because of the lack of effective adjuvant therapy, aggressive nature of the disease, and critical location of the tumor in close proximity to vital structures such as the hepatic artery and the portal vein. Moreover, the operative approach is dictated by the location of the tumor and the presence of underlying liver disease. During the past 4 decades, the operative management of CCA has evolved from a treatment modality that primarily aimed at palliation to curative intent with an aggressive surgical approach to R0 resection and total hepatectomy followed by orthotopic liver transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 20005336     DOI: 10.1016/j.transproceed.2009.11.001

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  20 in total

1.  Using the modern Silverhawk™ atherectomy catheter to characterize biliary structures that appear malignant: review of initial experience.

Authors:  Jason J Schwartz; Heather F Thiesset; Frederic Clayton; Douglas G Adler; William R Hutson; James G Carlisle
Journal:  HPB (Oxford)       Date:  2011-11       Impact factor: 3.647

2.  Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.

Authors:  W F Shen; W Zhong; Q Liu; C J Sui; Y Q Huang; J M Yang
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

3.  Management of primary sclerosing cholangitis.

Authors:  Holger H Lutz; Jens Jw Tischendorf
Journal:  World J Hepatol       Date:  2011-06-27

4.  A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.

Authors:  Huabang Zhou; Xiaolan Jiang; Qiaomei Li; Jingyi Hu; Zhengrong Zhong; Hao Wang; Hui Wang; Bing Yang; Heping Hu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 5.  Liver transplantation in the management of perihilar cholangiocarcinoma.

Authors:  Aliya F Gulamhusein; William Sanchez
Journal:  Hepat Oncol       Date:  2015-11-06

6.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

Review 7.  Update on the Diagnosis and Treatment of Cholangiocarcinoma.

Authors:  Bryan Doherty; Vinod E Nambudiri; William C Palmer
Journal:  Curr Gastroenterol Rep       Date:  2017-01

8.  XRCC1 Arg194Trp and Arg399Gln polymorphisms and risk of extrahepatic cholangiocarcinoma: a hospital-based case-control study in China.

Authors:  Yuanfeng Gong; Ming Qi; Jun Chen; Runya Fang; Cong Mai; Tiejun Chen; Hui Tang; Yunqiang Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells.

Authors:  Jianjun Zhang; Zhichao Zheng; Yan Zhao; Tao Zhang; Xiaohu Gu; Wei Yang
Journal:  Clin Exp Med       Date:  2012-09-07       Impact factor: 3.984

10.  Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.

Authors:  Xinsen Xu; Linhua Yang; Wei Chen; Min He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.